Leveraging new technologies in gluten related disorders: Benefits before and after diagnosis

Contemporary serologic testing has revolutionized the field of celiac disease. Highly accurate serologic assays have shown the prevalence of celiac disease to be nearly 1:100 in many populations. These commonly used tests allow noninvasive screening and detection. However, the variety of available serologic and genetic tests necessitates review of clinical utility as single tests or used in combination.

This presentation explores celiac disease and other gluten-related disorders, including updates on diagnostic algorithms and biomarkers, followed by an expert review of the BIO-FLASH system which utilizes chemiluminescent technology.